QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
Log in
ASX:API

Australian Pharmaceutical Industries Limited (API.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$1.09
MA: A$1.09▼
A$1.09
52-Week Range N/A
Volume453,647 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield1.73%
BetaN/A
Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. It also retails health and beauty products to consumers through a network of Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores in Australia; sells beauty products through Clear Skincare network of clinics in Australia and New Zealand; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and non-invasive aesthetic beauty services. The company was founded in 1910 and is based in Camberwell, Australia.

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.65 out of 5 stars


Industry, Sector and Symbol

Stock Exchange ASX
Industry Medical Equipment Wholesale
Sub-IndustryN/A
SectorServices
Current SymbolASX:API
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.api.net.au
Phone+61-3-88553000
EmployeesN/A

Debt

Debt-to-Equity Ratio56.99
Current Ratio1.17
Quick Ratio0.73

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$4.02 billion
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow8.26
Book ValueA$0.92 per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive API News and Ratings via Email

Sign-up to receive the latest news and ratings for API and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Australian Pharmaceutical Industries Limited (API.AX) (ASX:API) Frequently Asked Questions

What stocks does MarketBeat like better than Australian Pharmaceutical Industries Limited (API.AX)?

Wall Street analysts have given Australian Pharmaceutical Industries Limited (API.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Australian Pharmaceutical Industries Limited (API.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Australian Pharmaceutical Industries Limited (API.AX)'s earnings last quarter?

Australian Pharmaceutical Industries Limited (API.AX) (ASX:API) posted its earnings results on Wednesday, April, 17th. The company reported $0.05 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.05 by $0.00.
View Australian Pharmaceutical Industries Limited (API.AX)'s earnings history.

How often does Australian Pharmaceutical Industries Limited (API.AX) pay dividends? What is the dividend yield for Australian Pharmaceutical Industries Limited (API.AX)?

Australian Pharmaceutical Industries Limited (API.AX) declared a Final dividend on Thursday, October 22nd. Stockholders of record on Tuesday, December 15th will be paid a dividend of 0.02 per share on Tuesday, December 15th. This represents a dividend yield of 1.88%. The ex-dividend date is Wednesday, November 11th.
View Australian Pharmaceutical Industries Limited (API.AX)'s dividend history.

Who are some of Australian Pharmaceutical Industries Limited (API.AX)'s key competitors?

Some companies that are related to Australian Pharmaceutical Industries Limited (API.AX) include (ITQ.L) (ITQ), (SVCA.L) (SVCA), Air France-KLM SA (AF.PA) (AF), AllDigital (ADGL), ALS Limited (ALQ.AX) (ALQ), Astika (ASKH), Auckland International Airport Limited (AIA.AX) (AIA), Autogrill S.p.A. (AGL.MI) (AGL), Automotive Holdings Group (AHG), Autosports Group Limited (ASG.AX) (ASG), Baltia Air Lines (BLTA), Bapcor Limited (BAP.AX) (BAP), Barloworld Limited (BWO.L) (BWO), Brambles Limited (BXB.AX) (BXB) and Brinker International (EAT).
View all competitors.

What other stocks do shareholders of Australian Pharmaceutical Industries Limited (API.AX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Australian Pharmaceutical Industries Limited (API.AX) investors own include Capricorn Metals Ltd (CMM.AX) (CMM), Austal Limited (ASB.AX) (ASB), Mod Resources (MOD), Harvey Norman Holdings Limited (HVN.AX) (HVN), Evolution Mining Limited (EVN.AX) (EVN) and Downer EDI Limited (DOW.AX) (DOW).

Who are Australian Pharmaceutical Industries Limited (API.AX)'s key executives?

Australian Pharmaceutical Industries Limited (API.AX)'s management team includes the following people:
  • Mr. Richard C. Vincent C.P.A., B.Bus, (Accountancy), CPA, MD, CEO & Exec. Director
  • Mr. Peter Mendo, Chief Financial Officer
  • Mr. Dean Matthews, Chief Information Officer
  • Ms. Anne Mustow B.Com., L.L.B., Gen. Counsel & Company Sec.
  • Mr. Stephen Arthurson, Gen. Mang. of People
  • Mr. D. Glance, NSW State Mang.

What is Australian Pharmaceutical Industries Limited (API.AX)'s stock symbol?

Australian Pharmaceutical Industries Limited (API.AX) trades on the ASX under the ticker symbol "API."

How big of a company is Australian Pharmaceutical Industries Limited (API.AX)?

Australian Pharmaceutical Industries Limited (API.AX) has a market capitalization of $0.00 and generates $4.02 billion in revenue each year.

What is Australian Pharmaceutical Industries Limited (API.AX)'s official website?

The official website for Australian Pharmaceutical Industries Limited (API.AX) is www.api.net.au.

How can I contact Australian Pharmaceutical Industries Limited (API.AX)?

Australian Pharmaceutical Industries Limited (API.AX)'s mailing address is L 5 250 Camberwell Rd, MELBOURNE, VIC 3124, Australia. The company can be reached via phone at +61-3-88553000.

This page was last updated on 11/30/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.